Susquehanna International Group, LLP Talis Biomedical Corp Transaction History

Susquehanna International Group, LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$0.44 - $0.54 $4,609 - $5,657	10,476 New	10,476 $5,000
Q4 2022 Feb 14, 2023	BUY	$0.45 - $11.67 $8,734 - $226,503	19,409 New	19,409 $8,000
Q2 2022 Aug 15, 2022	BUY	$0.81 - $1.44 $1,379 - $2,452	1,703 Added 15.76%	12,508 $10,000
Q1 2022 May 16, 2022	SELL	$1.3 - $4.19 $1,835 - $5,916	-1,412 Reduced 11.56%	10,805 $15,000
Q4 2021 Feb 14, 2022	BUY	$3.81 - $6.17 $46,546 - $75,378	12,217 New	12,217 $49,000

Ticker TLIS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 26,619,200
Market Cap $45.8M
Description
Talis Biomedical Corporation operates as a molecular diagnostic company. The company is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. It also offers Talis One COVID-19 Test System, which focuses on detection of SARS-CoV-2, the virus that causes COVID-19. ...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.